WO2009078475A1 - Process for production of pyrazolinone derivative - Google Patents

Process for production of pyrazolinone derivative Download PDF

Info

Publication number
WO2009078475A1
WO2009078475A1 PCT/JP2008/073140 JP2008073140W WO2009078475A1 WO 2009078475 A1 WO2009078475 A1 WO 2009078475A1 JP 2008073140 W JP2008073140 W JP 2008073140W WO 2009078475 A1 WO2009078475 A1 WO 2009078475A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
general formula
atom
derivative
acid
Prior art date
Application number
PCT/JP2008/073140
Other languages
French (fr)
Japanese (ja)
Inventor
Fumi Yonehara
Takao Inoguchi
Original Assignee
Sumitomo Chemical Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Company, Limited filed Critical Sumitomo Chemical Company, Limited
Priority to CN2008801208809A priority Critical patent/CN101896466A/en
Publication of WO2009078475A1 publication Critical patent/WO2009078475A1/en
Priority to IL206085A priority patent/IL206085A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Definitions

  • the present invention may be referred to as a compound represented by the general formula (1) [hereinafter referred to as a virazolinone compound (1). ] And a compound represented by the general formula (2) [hereinafter sometimes referred to as acid halide (2). ] In the presence of a base, and a compound represented by the general formula (3) [hereinafter sometimes referred to as a birazolinone derivative (3). ] Related to the method of manufacturing.
  • R 1 R 2 , R 3 , R 4 and R 5 each represents a hydrogen atom, a halogen atom or a methyl group which may be substituted with a halogen atom.
  • R 6 represents a hydrogen atom or a carbon number:! Represents an alkyl group of ⁇ 5.
  • R 7 represents an alkyl group having 1 to 5 carbon atoms, an alkenyl group having 3 to 5 carbon atoms, or 3 to 5 carbon atoms. Represents an alkynyl group of
  • the virazolinone derivative (3) is useful, for example, as a raw material for agricultural chemicals. Background art
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2 00 0-2 2 6 3 74 discloses that a bisazolinone compound (1) and an acid halide (2) are mixed with water and hydrophobic. It is disclosed that a pyrazolinone derivative (3) is produced by reacting in a mixed solution with a basic organic solvent in the presence of a base, acid-treating the obtained reaction mixture without oil-water separation, and solvent extraction. ing. Disclosure of the invention
  • the yield is not always satisfactory.
  • a urea compound having a structure in which two molecules of bisazolinone compound (1) are connected by a carbonyl group is produced as a by-product. It is easy to be incorporated into the precipitate of the virazolinone derivative (3), the quality is lowered, and it is not preferable for the post-process using the virazolinone derivative (3).
  • an object of the present invention is to provide a method capable of producing the virazolinone derivative (3) with good quality by suppressing the incorporation of the above-mentioned by-product with good yield.
  • the inventors of the present invention reacted the bisazolinone compound (1) and the acid halide (2) in a mixed solution of water and a hydrophobic organic solvent in the presence of a base, and obtained the reaction mixture. It was found that by separating the oil and water and neutralizing the aqueous layer by adding an acid, the virazolinone derivative (3) is precipitated and separated, thereby improving the yield and suppressing the uptake of the by-product. It came to be completed.
  • the present invention comprises reacting a bisazolinone compound (1) and an acid halide (2) in a mixture of water and a hydrophobic organic solvent in the presence of a base, separating the resulting reaction mixture from oil to water,
  • the present invention provides a method for producing a pyrazolinone derivative characterized in that an acid is added to neutralize to precipitate a razolinone derivative (3) and separate it.
  • the virazolinone derivative (3) can be produced in good quality with good quality.
  • RR 2 , R 3 , R 4 and R 5 each represent a hydrogen atom, a halogen atom or a methyl group which may be substituted with a halogen atom.
  • R 6 is a hydrogen atom or a C 1-5 carbon atom. Represents an alkyl group.
  • the halogen atom is a fluorine atom, a chlorine atom, a bromine atom or It can be an iodine atom.
  • the methyl group substituted with a halogen atom may be a monohalomethyl group such as a monofluoromethyl group or a monochloromethyl group, or a dihalomethyl group such as a difluoromethyl group or a dichloromethyl group.
  • R 6 is an alkyl group having 1 to 5 carbon atoms
  • examples of the alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butynole group, a sec-butyl group, Examples thereof include an isobutyl group, a tert-butyl group, and an n-pentyl group.
  • R 7 represents an alkyl group having 1 to 5 carbon atoms, an alkenyl group having 3 to 5 carbon atoms, or 3 to 5 carbon atoms. Represents an alkynyl group of
  • R 7 when R 7 is an alkyl group having 1 to 5 carbon atoms, examples of the alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-propyl group, a sec-butyl group. Group, isobutyl group, tert-butyl group, n-pentyl group and the like.
  • R 7 is an alkenyl group having 3 to 5 carbon atoms
  • Examples of the alkyl group include an aryl group (2-propenyl group), a methallyl group (2-methyl-2-propenyl group), a crotyl group (2-butyr group), and the like.
  • R 7 is an alkynyl group having 3 to 5 carbon atoms
  • examples of the alkynyl group include a 2-probule group, a 2-petitinyl group, and a 3-petitinyl group.
  • the reaction between the lazolinone compound (1) and the acid halide (2) is carried out in the presence of a base.
  • examples of the base include alkali metal hydroxides such as lithium hydroxide, sodium hydroxide, and potassium hydroxide, alkaline earth metal hydroxides such as magnesium hydroxide and calcium hydroxide, and carbonic acid.
  • Alkaline metal carbonates such as sodium and carbonated lithium
  • inorganic bases such as alkali metal bicarbonates such as sodium bicarbonate and hydrogen carbonate, pyridine, 4_ (dimethylamino) pyridine
  • organic bases such as triethylamine.
  • the inorganic base it can also be used as an aqueous solution.
  • an alkali metal hydroxide aqueous solution is used.
  • the amount of the acid halide (2) used for the reaction is usually 0.5 to 5 mol, preferably 0.9 to 1.5 mol, relative to 1 mol of the bisazolinone compound (1).
  • the amount of the base used in the reaction is usually 1 to 5 mol, preferably 1.5 to 2.5 mol, per 1 mol of the lazolinone compound (1).
  • the reaction is carried out in the presence of a base with a bisazolinone compound (1) and an acid halide (2) in a mixture of water and an organic solvent.
  • hydrophobic organic solvent examples include aromatic hydrocarbons such as benzene, toluene, xylene, and black benzene, aliphatic hydrocarbons such as n-hexane and n-heptane, cyclopentane, and cyclohexane.
  • Alicyclic hydrocarbons such as hexane, ketones such as methyl ethyl ketone, methyl isobutyl ketone, ethers such as jetyl ether, dibutyl ether, tetrahydrofuran, and tetrahydrobrobilan. These can be used alone or in combination of two or more.
  • a hydrophilic organic solvent such as alcohol such as methanol, ethanol or propanol can be used.
  • Water and hydrophobic organic solvent may be added to the reactor in advance, A mixture with the zolinone compound (1) or the acid halide (2) may be added.
  • the total amount of the water, the hydrophobic organic solvent and the hydrophilic organic solvent is usually 1 to 20 parts by weight, preferably 1 to 10 parts by weight per 1 part by weight of the pyrazolinone compound (1). .
  • the reaction temperature is usually 0 to 100 ° C, preferably 10 to 50 ° C.
  • the reaction is usually performed near normal pressure, but may be performed under pressure or under reduced pressure as necessary.
  • any of a continuous method, a semi-continuous method, and a batch method can be adopted.
  • the pH during the reaction is usually 10 or more, and is usually adjusted by adding a base or an acid such as hydrochloric acid.
  • the order of preparation is not particularly limited, and the acid halide (2) may be added to the mixture of the bisazolinone compound (1) and the base, and the mixture of the bisazolinone compound (1) and the base is added to the acid halide (2). May be added.
  • reaction mixture After completion of the reaction, the reaction mixture is separated into oil and water, neutralized by adding acid to the aqueous layer, and the desired general formula (3)
  • the violazolinone derivative (3) represented by is precipitated as a solid and separated.
  • Examples of the acid added to the aqueous layer include hydrogen chloride and sulfuric acid, and an aqueous solution thereof is preferably used.
  • the amount of the acid to be used is generally 0.5 to 5 mol, preferably 0.7 to 1.5 mol, per 1 mol of the birazolinone compound (1).
  • the pH of the aqueous layer after addition of the acid is preferably 5 or more.
  • the pH of the aqueous layer after addition of the acid is The pH is preferably 9 or less. The pH can be adjusted by adjusting the amount of acid used.
  • it is preferable that the aqueous layer before adding the acid is in a state in which the virazolinone derivative (3) is dissolved.
  • the time for adding the acid to the aqueous layer is 3 hours or more in order to suppress the incorporation of the by-product into the precipitated virazolinone derivative (3).
  • the upper limit is not particularly limited, but is usually 20 hours or less from the viewpoint of productivity.
  • the acid is added to precipitate the virazolinone derivative (3), and then the virazolinone derivative (3) is separated from the aqueous layer containing the precipitate by a known separation means such as filtration.
  • a known separation means such as filtration.
  • the target product, virazolinone derivative (3) can be obtained as a solid.
  • the virazolinone derivative (3) can be obtained in good yield and with good quality while suppressing the by-product incorporation. Furthermore, it can be purified by means such as recrystallization or column chromatography if necessary.
  • the virazolinone derivative (3) can be produced in good quality with good quality.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Disclosed is a process for producing a pyrazolinone derivative (3), which is characterized by: reacting a pyrazolinone compound (1) with an acid halide (2) in a mixed solution of water and an organic solvent in the presence of a base; subjecting the resulting reaction mixture to the oily-layer/aqueous-layer separation; adding an acid to the aqueous layer to neutralize the aqueous layer, thereby causing the precipitation of the pyrazolinone derivative (3); and separating the pyrazolinone derivative (3). (1) (e.g., 3-amino-4-(2-methylphenyl)-pyrazolin-5-one) (2) (e.g., allylchlorothioformate) (3) (e.g., 1-[(2-propenylthio)carbonyl]-4-(2-methylphenyl)-5- amino-1H-pyrazol-3-one)

Description

明 細 書 ピラゾリノン誘導体の製造法 技術分野  Technical description Manufacturing method of pyrazolinone derivatives Technical field
本発明は、 一般式 ( 1 ) で示される化合物 〔以下、 ビラゾリノ ン化合物 ( 1 ) ということがある。 〕 と、 一般式 (2) で示される化合物 〔以下、 酸ハロゲン化 物 (2) ということがある。 〕 を塩基存在下で反応させ、 一般式 (3) で示され る化合物 〔以下、 ビラゾリノン誘導体 (3) ということがある。 〕 を製造する方 法に関する。  The present invention may be referred to as a compound represented by the general formula (1) [hereinafter referred to as a virazolinone compound (1). ] And a compound represented by the general formula (2) [hereinafter sometimes referred to as acid halide (2). ] In the presence of a base, and a compound represented by the general formula (3) [hereinafter sometimes referred to as a birazolinone derivative (3). ] Related to the method of manufacturing.
Figure imgf000003_0001
Figure imgf000003_0001
(式中、 R1 R2、 R3、 R4及び R5はそれぞれ水素原子、 ハロゲン原子又はハ ロゲン原子で置換されていてもよいメチル基を表す。 R6は水素原子又は炭素数 :!〜 5のアルキル基を表す。 ) (Wherein R 1 R 2 , R 3 , R 4 and R 5 each represents a hydrogen atom, a halogen atom or a methyl group which may be substituted with a halogen atom. R 6 represents a hydrogen atom or a carbon number:! Represents an alkyl group of ˜5.)
O O
X Y-R7 X YR 7
(式中、 Xは塩素原子又は臭素原子を表し、 Yは酸素原子又は硫黄原子を表す。 R 7は炭素数 1〜 5のアルキル基、 炭素数 3〜 5のアルケニル基又は炭素数 3〜 5のアルキニル基を表す。 ) (In the formula, X represents a chlorine atom or a bromine atom, Y represents an oxygen atom or a sulfur atom. R 7 represents an alkyl group having 1 to 5 carbon atoms, an alkenyl group having 3 to 5 carbon atoms, or 3 to 5 carbon atoms. Represents an alkynyl group of
Figure imgf000003_0002
Figure imgf000003_0002
(式中、 Rl、 R2、 R3、 R4、 R5、 R6、 R 7及ぴ Yはそれぞれ前記と同じ意味 を表す。 ) (Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and Y have the same meanings as described above.)
ビラゾリノン誘導体 (3) は、 例えば、 農薬の原料として有用である。 背景技術 The virazolinone derivative (3) is useful, for example, as a raw material for agricultural chemicals. Background art
ピラゾリノン誘導体 ( 3 ) の製造方法として、 例えば特開 2 0 0 0— 2 2 6 3 7 4号公報 (特許文献 1 ) には、 ビラゾリノン化合物 ( 1 ) と酸ハロゲン化物 ( 2) を水と疎水性有機溶媒との混合液中で塩基存在下に反応させ、 得られた反応 混合物を油水分離することなく酸処理し、 溶媒抽出することにより、 ピラゾリノ ン誘導体 (3) を製造することが開示されている。 発明の開示  As a method for producing a pyrazolinone derivative (3), for example, Japanese Patent Application Laid-Open No. 2 00 0-2 2 6 3 74 (Patent Document 1) discloses that a bisazolinone compound (1) and an acid halide (2) are mixed with water and hydrophobic. It is disclosed that a pyrazolinone derivative (3) is produced by reacting in a mixed solution with a basic organic solvent in the presence of a base, acid-treating the obtained reaction mixture without oil-water separation, and solvent extraction. ing. Disclosure of the invention
上記従来の方法では収率が必ずしも満足できるものではない。 また反応の際に は、 目的物であるビラゾリノン誘導体 (3) の他に、 2分子のビラゾリノン化合 物 (1 ) がカルボニル基によって繋がった構造を持つ尿素化合物が副生するが、 この副生物はビラゾリノン誘導体 (3) の析出物中に取り込まれ易く、 品質が低 下し、 ビラゾリノン誘導体 (3) を使用する後工程にとって好ましくない。  In the above conventional method, the yield is not always satisfactory. During the reaction, in addition to the target bisazolinone derivative (3), a urea compound having a structure in which two molecules of bisazolinone compound (1) are connected by a carbonyl group is produced as a by-product. It is easy to be incorporated into the precipitate of the virazolinone derivative (3), the quality is lowered, and it is not preferable for the post-process using the virazolinone derivative (3).
そこで、 本発明の目的は、 収率良く、 上記副生物の取り込みを抑制して、 良好 な品質でビラゾリノン誘導体 (3) を製造しうる方法を提供することにある。 本発明者らは鋭意研究を行った結果、 ビラゾリノン化合物 (1 ) と酸ハロゲン 化物 (2) を塩基存在下、 水と疎水性有機溶媒との混合液中で反応させ、 得られ た反応混合物を油水分離し、 水層に酸を加えて中和することによりビラゾリノン 誘導体 (3) を析出させ、 分離することによって、 収率が向上し、 上記副生物の 取り込みが抑制できることを見出し、 本発明を完成するに至った。  Accordingly, an object of the present invention is to provide a method capable of producing the virazolinone derivative (3) with good quality by suppressing the incorporation of the above-mentioned by-product with good yield. As a result of intensive studies, the inventors of the present invention reacted the bisazolinone compound (1) and the acid halide (2) in a mixed solution of water and a hydrophobic organic solvent in the presence of a base, and obtained the reaction mixture. It was found that by separating the oil and water and neutralizing the aqueous layer by adding an acid, the virazolinone derivative (3) is precipitated and separated, thereby improving the yield and suppressing the uptake of the by-product. It came to be completed.
すなわち本発明は、 ビラゾリノン化合物 (1 ) と酸ハロゲン化物 (2) を塩基 存在下、 水と疎水性有機溶媒との混合液中で反応させ、 得られた反応混合物を油 水分離し、 水層に酸を加えて中和し、 ビラゾリノン誘導体 (3) を析出させ、 分 離することを特徴とするピラゾリノン誘導体の製造方法を提供するものである。 本発明によれば、 収率良く、 ビラゾリノン誘導体 (3) を良好な品質で製造す ることができる。 発明を実施するための形態 以下に本発明について詳細に説明する。 ビラゾリ ノン化合物 ( 1 ) を示す一般 式 ( 1 ) That is, the present invention comprises reacting a bisazolinone compound (1) and an acid halide (2) in a mixture of water and a hydrophobic organic solvent in the presence of a base, separating the resulting reaction mixture from oil to water, The present invention provides a method for producing a pyrazolinone derivative characterized in that an acid is added to neutralize to precipitate a razolinone derivative (3) and separate it. According to the present invention, the virazolinone derivative (3) can be produced in good quality with good quality. BEST MODE FOR CARRYING OUT THE INVENTION The present invention is described in detail below. General formula (1) indicating a bisazolinone compound (1)
Figure imgf000005_0001
Figure imgf000005_0001
(式中、 R R2、 R3、 R4及び R5はそれぞれ水素原子、 ハロゲン原子又はハ ロゲン原子で置換されていてもよいメチル基を表す。 R6は水素原子又は炭素数 1〜 5のアルキル基を表す。 ) (Wherein RR 2 , R 3 , R 4 and R 5 each represent a hydrogen atom, a halogen atom or a methyl group which may be substituted with a halogen atom. R 6 is a hydrogen atom or a C 1-5 carbon atom. Represents an alkyl group.)
において、 R1 R2、 R3、 R4及び R5の少なく とも 1つがハロゲン原子又はハ ロゲン原子で置換されたメチル基である場合、 このハロゲン原子は、 フッ素原子 、 塩素原子、 臭素原子又はヨウ素原子であることができる。 また、 ハロゲン原子 で置換されたメチル基は、 モノフルォロメチル基やモノクロロメチル基の如きモ ノハロメチル基であってもよいし、 ジフルォロメチル基ゃジクロロメチル基の如 きジハ口メチル基であってもよいし、 トリ フルォロメチル基やト リクロロメチル 基の如き トリハロメチル基であってもよい。 R6が炭素数 1〜 5のアルキル基で ある場合、 このアルキル基と しては、 例えば、 メチル基、 ェチル基、 n—プロピ ル基、 イソプロピル基、 n—ブチノレ基、 s e c—ブチル基、 イソブチル基、 t e r t一ブチル基、 n—ペンチル基等が挙げられる。 In this case, when at least one of R 1 R 2 , R 3 , R 4 and R 5 is a methyl group substituted with a halogen atom or a halogen atom, the halogen atom is a fluorine atom, a chlorine atom, a bromine atom or It can be an iodine atom. The methyl group substituted with a halogen atom may be a monohalomethyl group such as a monofluoromethyl group or a monochloromethyl group, or a dihalomethyl group such as a difluoromethyl group or a dichloromethyl group. Alternatively, it may be a trihalomethyl group such as a trifluoromethyl group or a trichloromethyl group. When R 6 is an alkyl group having 1 to 5 carbon atoms, examples of the alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butynole group, a sec-butyl group, Examples thereof include an isobutyl group, a tert-butyl group, and an n-pentyl group.
酸ハロゲン化物 (2) を示す一般式 (2)
Figure imgf000005_0002
General formula (2) indicating acid halide (2)
Figure imgf000005_0002
(式中、 Xは塩素原子又は臭素原子を表し、 Yは酸素原子又は硫黄原子を表す。 R7は炭素数 1〜 5のアルキル基、 炭素数 3〜 5のアルケニル基又は炭素数 3〜 5のアルキニル基を表す。 ) (In the formula, X represents a chlorine atom or a bromine atom, Y represents an oxygen atom or a sulfur atom. R 7 represents an alkyl group having 1 to 5 carbon atoms, an alkenyl group having 3 to 5 carbon atoms, or 3 to 5 carbon atoms. Represents an alkynyl group of
において、 R7が炭素数 1〜 5のアルキル基である場合、 このアルキル基と して は、 例えば、 メチル基、 ェチル基、 n _プロピル基、 イソプロピル基、 n—プチ ル基、 s e c一ブチル基、 イソブチル基、 t e r t一ブチル基、 n—ペンチル基 等が挙げられる。 R7が炭素数 3〜 5のアルケニル基である場合、 このアルケニ ル基としては、 例えば、 ァリル基 (2—プロぺニル基) 、 メタリル基 ( 2—メチ ル— 2—プロぺニル基) 、 クロチル基 (2—ブテュル基) 等が挙げられる。 R 7 が炭素数 3〜 5のアルキニル基である場合、 このアルキニル基と しては、 例えば 、 2—プロビュル基、 2—プチニル基又は 3—プチニル基等が挙げられる。 ビラゾリノ ン化合物 ( 1 ) と酸ハロゲン化物 (2 ) との反応は、 塩基存在下で 行われる。 塩基と しては、 例えば、 水酸化リチウム、 水酸化ナトリ ウム、 水酸化 カリ ウムのようなアルカリ金属水酸化物、 水酸化マグネシウム、 水酸化カルシゥ ムのようなアルカリ土類金属水酸化物、 炭酸ナトリ ウム、 炭酸力リ ウムのような アル力リ金属炭酸塩、 炭酸水素ナトリ ウム、 炭酸水素力リ ゥムのようなアルカリ 金属重炭酸塩等の無機塩基や、 ピリジン、 4 _ (ジメチルァミノ) ピリジン、 ト リエチルァミ ン等の有機塩基が挙げられる。 上記無機塩基を使用する場合、 水溶 液として使用することもできる。 好ましくはアルカリ金属水酸化物の水溶液を用 いる。 In this case, when R 7 is an alkyl group having 1 to 5 carbon atoms, examples of the alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-propyl group, a sec-butyl group. Group, isobutyl group, tert-butyl group, n-pentyl group and the like. When R 7 is an alkenyl group having 3 to 5 carbon atoms, Examples of the alkyl group include an aryl group (2-propenyl group), a methallyl group (2-methyl-2-propenyl group), a crotyl group (2-butyr group), and the like. When R 7 is an alkynyl group having 3 to 5 carbon atoms, examples of the alkynyl group include a 2-probule group, a 2-petitinyl group, and a 3-petitinyl group. The reaction between the lazolinone compound (1) and the acid halide (2) is carried out in the presence of a base. Examples of the base include alkali metal hydroxides such as lithium hydroxide, sodium hydroxide, and potassium hydroxide, alkaline earth metal hydroxides such as magnesium hydroxide and calcium hydroxide, and carbonic acid. Alkaline metal carbonates such as sodium and carbonated lithium, inorganic bases such as alkali metal bicarbonates such as sodium bicarbonate and hydrogen carbonate, pyridine, 4_ (dimethylamino) pyridine And organic bases such as triethylamine. When the inorganic base is used, it can also be used as an aqueous solution. Preferably, an alkali metal hydroxide aqueous solution is used.
反応に用いる酸ハロゲン化物 ( 2 ) の使用量は、 ビラゾリノン化合物 ( 1 ) 1 モルに対して、 通常 0 . 5〜 5モルであり、 好ましく は 0 . 9〜 1 . 5モルであ る。 反応に用いる塩基の使用量は、 ビラゾリ ノン化合物 ( 1 ) 1モルに対し、 通 常 1〜 5モルであり、 好ましくは 1 . 5〜 2 . 5モルである。  The amount of the acid halide (2) used for the reaction is usually 0.5 to 5 mol, preferably 0.9 to 1.5 mol, relative to 1 mol of the bisazolinone compound (1). The amount of the base used in the reaction is usually 1 to 5 mol, preferably 1.5 to 2.5 mol, per 1 mol of the lazolinone compound (1).
反応は、 塩基存在下、 ビラゾリ ノン化合物 ( 1 ) と酸ハロゲン化物 ( 2 ) を水 と有機溶媒の混合液中で行う。  The reaction is carried out in the presence of a base with a bisazolinone compound (1) and an acid halide (2) in a mixture of water and an organic solvent.
疎水性有機溶媒と しては、 例えば、 ベンゼン、 トルエン、 キシレン、 クロ口べ ンゼンのような芳香族炭化水素、 n—へキサン、 n —ヘプタンのような脂肪族炭 化水素、 シクロペンタン、 シクロへキサンのような脂環式炭化水素、 メチルェチ ルケトン、 メチルイソブチルケトンのようなケトン、 ジェチルエーテル、 ジブチ ルエーテル、 テ トラヒ ドロフラン、 テ トラヒ ドロビランのようなェ一テルなどが 挙げられ、 これらはそれぞれ単独で、 または 2種以上を組合せて用いることがで きる。  Examples of the hydrophobic organic solvent include aromatic hydrocarbons such as benzene, toluene, xylene, and black benzene, aliphatic hydrocarbons such as n-hexane and n-heptane, cyclopentane, and cyclohexane. Alicyclic hydrocarbons such as hexane, ketones such as methyl ethyl ketone, methyl isobutyl ketone, ethers such as jetyl ether, dibutyl ether, tetrahydrofuran, and tetrahydrobrobilan. These can be used alone or in combination of two or more.
疎水性有機溶媒と同時に、 メタノール、 エタノール、 プロパノールのようなァ ルコール等の親水性有機溶媒を使用することもできる。  Simultaneously with the hydrophobic organic solvent, a hydrophilic organic solvent such as alcohol such as methanol, ethanol or propanol can be used.
水と疎水性有機溶媒は、 予め反応器に添加しておいてもよいし、 それぞれビラ ゾリノン化合物 (1) または酸ハロゲン化物 (2) と混合して添加してもよい。 上記の水、 疎水性有機溶媒および親水性有機溶媒の合計使用量は、 ピラゾリノ ン化合物 (1) 1重量部に対し、 通常 1〜 20重量部であり、 好ましくは 1〜 1 0重量部である。 Water and hydrophobic organic solvent may be added to the reactor in advance, A mixture with the zolinone compound (1) or the acid halide (2) may be added. The total amount of the water, the hydrophobic organic solvent and the hydrophilic organic solvent is usually 1 to 20 parts by weight, preferably 1 to 10 parts by weight per 1 part by weight of the pyrazolinone compound (1). .
反応温度は通常 0〜 1 00°C、 好ましくは 1 0〜 50°Cである。 また、 反応は 、 通常、 常圧付近で行われるが、 必要により加圧下又は減圧下で行われてもよい 。 反応方式としては、 連続式、 半連続式、 回分式のいずれも採用することができ る。  The reaction temperature is usually 0 to 100 ° C, preferably 10 to 50 ° C. In addition, the reaction is usually performed near normal pressure, but may be performed under pressure or under reduced pressure as necessary. As the reaction method, any of a continuous method, a semi-continuous method, and a batch method can be adopted.
反応中の pHは通常 1 0以上であり、 通常は塩基あるいは塩酸などの酸を添加 することにより調整する。  The pH during the reaction is usually 10 or more, and is usually adjusted by adding a base or an acid such as hydrochloric acid.
仕込み順序には特に制限はなく、 ビラゾリノン化合物 ( 1) と塩基との混合物 に酸ハロゲン化物 (2) を加えてもよく、 酸ハロゲン化物 (2) にビラゾリノン 化合物 ( 1) と塩基との混合物を加えてもよい。  The order of preparation is not particularly limited, and the acid halide (2) may be added to the mixture of the bisazolinone compound (1) and the base, and the mixture of the bisazolinone compound (1) and the base is added to the acid halide (2). May be added.
反応終了後の反応混合物を油水分離し、 水層に酸を加えて中和し、 目的物であ る一般式 (3)  After completion of the reaction, the reaction mixture is separated into oil and water, neutralized by adding acid to the aqueous layer, and the desired general formula (3)
Figure imgf000007_0001
Figure imgf000007_0001
(式中、 I 1、 R2、 R3、 R4、 R5、 R6、 R7及び Yはそれぞれ前記と同じ意味 を表す。 ) (In the formula, I 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and Y have the same meanings as described above.)
で示されるビラゾリノン誘導体 (3) を固体として析出させ、 分離する。 The violazolinone derivative (3) represented by is precipitated as a solid and separated.
水層に加える酸としては、 例えば、 塩化水素や硫酸等が挙げられ、 その水溶液 が好ましく用いられる。 酸の使用量は、 ビラゾリノン化合物 ( 1) 1モルに対し 、 通常 0. 5〜 5モルであり、 好ましくは 0. 7〜 1. 5モルである。 品質面、 操作面から酸を加えた後の水層の p Hは 5以上であることが好ましく、 また、 ピ ラゾリノン誘導体 (3) を十分に析出させるため、 酸を加えた後の水層の p Hは 9以下であることが好ましい。 p Hの調整は、 酸の使用量を調整することで行う ことができる。 また、 酸を加える前の水層は、 ビラゾリ ノン誘導体 (3) が溶解した状態であ るのが好ましレ、。 Examples of the acid added to the aqueous layer include hydrogen chloride and sulfuric acid, and an aqueous solution thereof is preferably used. The amount of the acid to be used is generally 0.5 to 5 mol, preferably 0.7 to 1.5 mol, per 1 mol of the birazolinone compound (1). From the aspect of quality and operation, the pH of the aqueous layer after addition of the acid is preferably 5 or more. In order to sufficiently precipitate the pyrazolinone derivative (3), the pH of the aqueous layer after addition of the acid is The pH is preferably 9 or less. The pH can be adjusted by adjusting the amount of acid used. In addition, it is preferable that the aqueous layer before adding the acid is in a state in which the virazolinone derivative (3) is dissolved.
水層に酸を加える時間は、 析出するビラゾリ ノン誘導体 (3) への前記副生物 の取り込みを抑えるため、 3時間以上とする。 一方、 上限は特に限定されないが 、 生産性の観点から通常 20時間以下である。  The time for adding the acid to the aqueous layer is 3 hours or more in order to suppress the incorporation of the by-product into the precipitated virazolinone derivative (3). On the other hand, the upper limit is not particularly limited, but is usually 20 hours or less from the viewpoint of productivity.
酸を加え、 ビラゾリノン誘導体 (3) を析出させた後、 該析出物を含む水層を ろ過などの公知の分離手段によってビラゾリ ノン誘導体 (3) を分離する。 分離 した析出物を水や有機溶媒によって洗浄することにより、 目的物であるビラゾリ ノン誘導体 (3) を固体と して得ることができる。  The acid is added to precipitate the virazolinone derivative (3), and then the virazolinone derivative (3) is separated from the aqueous layer containing the precipitate by a known separation means such as filtration. By washing the separated precipitate with water or an organic solvent, the target product, virazolinone derivative (3), can be obtained as a solid.
かく して、 ビラゾリ ノン誘導体 (3) を、 収率良く、 前記副生物の取り込みを 抑制し、 良好な品質で得ることができる。 更に、 必要に応じて、 再結晶やカラム クロマ トグラフィ一等の手段により精製することも可能である。  Thus, the virazolinone derivative (3) can be obtained in good yield and with good quality while suppressing the by-product incorporation. Furthermore, it can be purified by means such as recrystallization or column chromatography if necessary.
実施例 Example
以下、 本発明の実施例を示すが、 本発明はこれによって限定されるものではな レ、。  Examples of the present invention will be described below, but the present invention is not limited thereto.
実施例 1 Example 1
還流冷却器、 温度計、 攪拌器、 滴下ロートを備えたガラス製反応器に、 3—ァ ミノ一 4一 (2—メチルフエニル) 一ビラゾリ ン一 5—オン 〔一般式 ( 1) にお いて R1がメチル基、 R2、 R3、 R4、 R5及び R6が水素原子である化合物〕 4 5 . 00 g ( 0. 238モル) 、 メタノ一ル 45. O O g、 水 1 6. 1 6 g、 キシ レン 45. 00 g及び 25 %水酸化ナトリ ゥム水溶液 39.96 gを入れ攪拌し た。 この水溶液に 1 0 %塩酸を加えて p Hを約 1 2.0に調整し、 1 5°Cにてァ リルクロロチォホルメート 〔一般式 (2) において Xが塩素原子、 Yが硫黄原子 、 R7がァリル基である化合物〕 34.44 g (0. 252モル) とキシレン 29 . 5 2 gの混合溶液を 2時間かけて滴下し、 滴下終了後、 同温度でさらに 2時間 攪拌した。 ァリルクロロチォホルメートの滴下及びその後の保温中、 1 0%水酸 化ナト リ ゥム溶液を併注して反応系内の p Hを約 1 0. 7に保った。 その後、 反 応混合物を 30分間静置して油水分離し、 水層に 2 5°Cにて 10%塩酸 82.3 4 gを 3時間かけて滴下し、 1— 〔 (2—プロぺニルチオ) カルボニル〕 _4一 (2—メチルフエニル) 一 5—アミノー 1 H—ピラゾ一ル一 3 _オン 〔一般式 ( 3) において R1がメチル基、 R R2、 R3、 R4、 R5及び R6が水素原子、 Y が硫黄原子、 R7がァリル基である化合物〕 を析出させた。 このときの ρ Ηは 6 . 5であった。 この析出物を含む水層をろ過した。 ろ上物を η—へキサン、 次い でメタノール水で洗浄し、 1— 〔 (2—プロぺニルチオ) カルボニル〕 _4一 ( 2_メチルフエ-ル) 一 5—ァミノ一 1 H—ピラゾール一 3—オンを 58.6 1 g得た。 これを高速液体クロマ トグラフィーにより分析し、 純度を絶対検量線法 により算出し、 原料である 3—ァミノ一 4— (2—メチルフエニル) 一ビラゾリ ン _ 5—オンに対する収率を求めた。. その結果、 純度 95. 9%、 収率85.2 %であった。 また、 副生物である尿素化合物の含有量を面積百分率法にて算出し たところ、 その含有量は 1. 1 %であった。 In a glass reactor equipped with a reflux condenser, thermometer, stirrer, and dropping funnel, add 3-amino-4-one (2-methylphenyl), 1-azolazoline, 5-on [R in general formula (1) Compound in which 1 is a methyl group, and R 2 , R 3 , R 4 , R 5 and R 6 are hydrogen atoms] 45.00 g (0.238 mol), methanol 45. OO g, water 1 6. 16 g, 45.00 g of xylene and 39.96 g of 25% aqueous sodium hydroxide solution were added and stirred. To this aqueous solution, 10% hydrochloric acid was added to adjust the pH to about 12.0, and then at 15 ° C, chlorochloroformate [In the general formula (2), X is a chlorine atom, Y is a sulfur atom, R Compound in which 7 is an aryl group] A mixed solution of 34.44 g (0.252 mol) and xylene 29.5 2 g was added dropwise over 2 hours. After completion of the addition, the mixture was further stirred at the same temperature for 2 hours. During the dropwise addition of allylchlorothioformate and subsequent incubation, 10% sodium hydroxide solution was added together to maintain the pH in the reaction system at about 10.7. Then, the reaction mixture is allowed to stand for 30 minutes to separate oil and water, and 10% hydrochloric acid 82.3 is added to the aqueous layer at 25 ° C. 4 g was added dropwise over 3 hours, 1- [(2-propenylthio) carbonyl] _4 one (2-methylphenyl) one 5-amino-1 H-pyrazol one 3 _one [in the general formula (3) R 1 is a methyl group, RR 2 , R 3 , R 4 , R 5 and R 6 are hydrogen atoms, Y is a sulfur atom, and R 7 is an aryl group]. Ρρ at this time was 6.5. The aqueous layer containing this precipitate was filtered. The filtered product was washed with η-hexane and then with methanol water. 1- [(2-Propenylthio) carbonyl] _4 1 (2_methylphenol) 1 5-Amino 1 1 H-pyrazole 1 3 — 58.6 1 g of ON was obtained. This was analyzed by high-performance liquid chromatography, and the purity was calculated by an absolute calibration curve method, and the yield relative to the starting material 3-amino-4- (2-methylphenyl) mono-biazolin-5-one was determined. As a result, the purity was 95.9% and the yield was 85.2%. The content of urea compound as a by-product was calculated by the area percentage method, and the content was 1.1%.
比較例 1 Comparative Example 1
実施例 1と同様の反応器に、 3—アミノー 4— (2—メチルフエニル) 一ビラ ゾリン _ 5_オン 1 5. 00 g (0. 079モル) 、 メタノーノレ 1 5. 00 g、 水 7.49 g、 キシレン 15. 00 g及び 25%水酸化ナト リ ウム水溶液 1 3. 3 2 gを入れ攪拌した。 この水溶液に 1 0 %塩酸を加えて p Hを 1 2.0に調整し 、 1 5 °Cにてァリルクロロチォホルメート 〔一般式 (2) において Xが塩素原子 、 Yが硫黄原子、 R7がァリル基である化合物〕 1 0.6 1 g (0. 078モル) とキシレン 9. 1 0 gの混合溶液を 2時間かけて滴下し、 滴下終了後、 同温度で さらに 2時間攪拌した。 ァリルクロロチォホルメ一トの滴下及びその後の保温中 、 1 0 %水酸化ナト リ ゥム溶液を併注して反応系内の p Hを約 1 0. 7に保った 。 その後、 反応混合物に 25 °Cにて 1 0 %塩酸 28. 5 7 gを 0.5時間かけて 滴下し、 1 _ 〔 (2—プロぺニルチオ) カルボニル〕 一4— (2—メチルフエ二 ル) 一 5—アミノー 1 H—ピラゾール一 3二オンを析出させた。 このときの pH は 6. 5であった。 これに n—へキサン 30. 00 gを加え 1時間攪拌後、 ろ過 した。 ろ上物を n—へキサン、 次いでメタノール水で洗浄し、 1一 〔 (2—プロ ぺニルチオ) カルボニル〕 一4— (2—メチルフエニル) ー 5—ァミ ノ一 1 H— ピラゾール一 3—オンを 1 9. 28 g得た。 実施例 1 と同様に分析したところ、 純度 9 5. 3%、 収率 8 5. 9 %であった。 上記尿素化合物の含有量は 1. 8 %で あった。 産業上の利用可能性 In the same reactor as in Example 1, 3-amino-4- (2-methylphenyl) monovirazolin_5_one 15.00 g (0.079 mol), methanolol 15.00 g, water 7.49 g, Xylene 15.00 g and 25% aqueous sodium hydroxide solution 1 3. 3 2 g were added and stirred. To this aqueous solution, 10% hydrochloric acid was added to adjust pH to 12.0, and at 15 ° C, allylchlorothioformate [in the general formula (2), X is a chlorine atom, Y is a sulfur atom, R 7 Compound in which is a aryl group] A mixed solution of 10.61 g (0.078 mol) and xylene 10.10 g was added dropwise over 2 hours. After completion of the addition, the mixture was further stirred at the same temperature for 2 hours. During the dropwise addition of allylic chloroformate and subsequent incubation, the pH in the reaction system was kept at about 10.7 by co-injecting 10% sodium hydroxide solution. Thereafter, 28.57 g of 10% hydrochloric acid was added dropwise to the reaction mixture at 25 ° C over 0.5 hours, and 1 _ [(2-propenylthio) carbonyl] 1- (2-methylphenyl) 1- 5-Amino-1 H-pyrazole 1-32one was precipitated. The pH at this time was 6.5. To this was added 30.00 g of n-hexane, and the mixture was stirred for 1 hour and filtered. The filtered product was washed with n-hexane and then with methanolic water, and 1 1 [(2-propenylthio) carbonyl] 1- (2-methylphenyl) -5-amino 1 H-pyrazole 1 3- 1 9.28 g of on was obtained. When analyzed in the same manner as in Example 1, The purity was 95.3% and the yield was 85.9%. The urea compound content was 1.8%. Industrial applicability
本発明によれば、 収率良く、 ビラゾリノン誘導体 (3) を良好な品質で製造す ることができる。  According to the present invention, the virazolinone derivative (3) can be produced in good quality with good quality.

Claims

請 求 の 範 囲 The scope of the claims
般式 (1) General formula (1)
Figure imgf000011_0001
Figure imgf000011_0001
(式中、 R'、 R2、 R3、 R4及び R5はそれぞれ水素原子、 ハロゲン原子又はハ ロゲン原子で置換されていてもよいメチル基を表す。 R 6は水素原子又は炭素数 1〜 5のアルキル基を表す。 ) で示されるビラゾリノン化合物と一般式 (2)
Figure imgf000011_0002
(In the formula, R ′, R 2 , R 3 , R 4 and R 5 each represents a hydrogen atom, a halogen atom or a methyl group which may be substituted with a halogen atom. R 6 represents a hydrogen atom or a carbon number of 1; Represents an alkyl group of ~ 5) and a bisazolinone compound represented by the general formula (2)
Figure imgf000011_0002
(式中、 Xは塩素原子又は臭素原子を表し、 Yは酸素原子又は硫黄原子を表す。 R 7は炭素数 1〜 5のアルキル基、 炭素数 3〜 5のアルケニル基又は炭素数 3〜 5のアルキニル基を表す。 ) で示される酸ハロゲン化物を塩基存在下、 水と疎水 性有機溶媒との混合液中で反応させ、 得られた反応混合物を油水分離し、 水層に 酸を加えて中和することにより一般式 (3) (In the formula, X represents a chlorine atom or a bromine atom, Y represents an oxygen atom or a sulfur atom. R 7 represents an alkyl group having 1 to 5 carbon atoms, an alkenyl group having 3 to 5 carbon atoms, or 3 to 5 carbon atoms. The acid halide represented by) is reacted in a mixed solution of water and a hydrophobic organic solvent in the presence of a base, the resulting reaction mixture is separated into oil and water, and an acid is added to the aqueous layer. General formula (3) by neutralization
Figure imgf000011_0003
Figure imgf000011_0003
(式中、 R R2、 R3、 R4、 R5、 R6、 R7及び Yはそれぞれ前記と同じ意味 を表す。 ) で示されるビラゾリノン誘導体を析出させ、 分離することを特徴とす るピラゾリノン誘導体の製造法。 (Wherein, RR 2 , R 3 , R 4 , R 5 , R 6 , R 7 and Y each have the same meaning as described above.) Are precipitated and separated. A method for producing a pyrazolinone derivative.
2. 2.
疎水性有機溶媒がトルエンおよび Zまたはキシレンであることを特徴とする請 求の範囲第 1項に記載の製造法。 2. The production method according to claim 1, wherein the hydrophobic organic solvent is toluene and Z or xylene.
3. 3.
一般式 ( 1 ) で示されるビラゾリ ノン化合物が 3—ァミノ一 4 _ ( 2—メチル フエニル) 一ビラゾリン一 5—オン、 一般式 (2) で示される酸ハロゲン化物が ァリルクロロチォホルメートであり、 生成物である一般式 ( 3) で示されるビラ ゾリ ノン誘導体が 1— 〔 ( 2—プロぺニルチオ) カルボニル〕 一 4— (2—メチ ルフエニル) _ 5—ァミノ _ 1 H—ピラゾール一 3—オンであることを特徴とす る請求の範囲第 1項または第 2項に記載の製造法。  The bisazolinone compound represented by the general formula (1) is 3-amino-4- (2-methylphenyl) mono-biazolin-5-one, and the acid halide represented by the general formula (2) is valylchlorothioformate. The product is a bisazolinone derivative represented by the general formula (3) 1-[(2-propenylthio) carbonyl] 1 4- (2-methylphenyl) _ 5-amino _ 1 H-pyrazole 3. The method according to claim 1 or 2, wherein the method is 3-on.
PCT/JP2008/073140 2007-12-14 2008-12-12 Process for production of pyrazolinone derivative WO2009078475A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN2008801208809A CN101896466A (en) 2007-12-14 2008-12-12 Process for production of pyrazolinone derivative
IL206085A IL206085A0 (en) 2007-12-14 2010-05-31 Process for producing of pyrazolinone derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-323130 2007-12-14
JP2007323130A JP2009143850A (en) 2007-12-14 2007-12-14 Method of preparing pyrazolinone derivative

Publications (1)

Publication Number Publication Date
WO2009078475A1 true WO2009078475A1 (en) 2009-06-25

Family

ID=40795586

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/073140 WO2009078475A1 (en) 2007-12-14 2008-12-12 Process for production of pyrazolinone derivative

Country Status (4)

Country Link
JP (1) JP2009143850A (en)
CN (1) CN101896466A (en)
IL (1) IL206085A0 (en)
WO (1) WO2009078475A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848517A (en) * 2019-04-30 2020-10-30 上海医药工业研究院 Preparation method of edaravone

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009298709A (en) * 2008-06-11 2009-12-24 Sumitomo Chemical Co Ltd Method of preparing pyrazolinone derivative

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283209A (en) * 1995-04-11 1996-10-29 Sumitomo Chem Co Ltd Production of allylamine
JPH08295654A (en) * 1995-04-27 1996-11-12 Sumitomo Chem Co Ltd Purification of aniline
JP2000226374A (en) * 1998-04-23 2000-08-15 Sumitomo Chem Co Ltd Pyrazolinone derivative
JP2005239603A (en) * 2004-02-25 2005-09-08 Sumitomo Chemical Co Ltd Method for producing 2-imidazolidinones
JP2007302619A (en) * 2006-05-12 2007-11-22 Sumitomo Chemical Co Ltd Method for producing pyrazolinone derivative

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283209A (en) * 1995-04-11 1996-10-29 Sumitomo Chem Co Ltd Production of allylamine
JPH08295654A (en) * 1995-04-27 1996-11-12 Sumitomo Chem Co Ltd Purification of aniline
JP2000226374A (en) * 1998-04-23 2000-08-15 Sumitomo Chem Co Ltd Pyrazolinone derivative
JP2005239603A (en) * 2004-02-25 2005-09-08 Sumitomo Chemical Co Ltd Method for producing 2-imidazolidinones
JP2007302619A (en) * 2006-05-12 2007-11-22 Sumitomo Chemical Co Ltd Method for producing pyrazolinone derivative

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848517A (en) * 2019-04-30 2020-10-30 上海医药工业研究院 Preparation method of edaravone
CN111848517B (en) * 2019-04-30 2023-04-07 上海医药工业研究院 Preparation method of edaravone

Also Published As

Publication number Publication date
JP2009143850A (en) 2009-07-02
CN101896466A (en) 2010-11-24
IL206085A0 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
US7863460B2 (en) Process for producing 1-substituted-3-fluoroalkylpyrazole-4-carboxylate
JP2007326784A (en) Method for producing 1-substituted-5-fluoroalkylpyrazole-4-carboxylic acid ester
KR101653025B1 (en) Method for producing 2-amino-4-(trifluoromethyl)pyridine
WO2009078475A1 (en) Process for production of pyrazolinone derivative
HUE032621T2 (en) Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine
JP2008222710A (en) Production method of 4-methyl-2,3,5,6-tetrafluorobenzyl alcohol
JP4862481B2 (en) Method for producing pyrazolinone derivatives
JP5181609B2 (en) Method for producing pyrazolinone derivative
KR101180563B1 (en) Process for Producing Hydrazone Compound
JP5139104B2 (en) Method for producing dibenzooxepin compound
WO2018180943A1 (en) Method for producing halogen-containing pyrazol carboxylic acid and intermediate thereof
JP2012519195A (en) Chemical methods for the production of haloalkenone ethers
US7081548B2 (en) Process for preparing 3-chloro-5-nitrotoluene
JP2009298709A (en) Method of preparing pyrazolinone derivative
JP2002179622A (en) Method for producing 4-acetoxystyrene
US9650337B2 (en) Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate
JP2009067710A (en) Method for producing n-methacryloyl-4-cyano-3-trifluoromethylaniline
US11649213B2 (en) Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
WO2007072841A1 (en) Process for producing 2-oxindole compound
JP2002338558A (en) Method for producing (4-alkyl-1-piperazinylmethyl)benzoic acid derivative
US20220033352A1 (en) Synthetic method for the preparation of an alkoxymethylene-benzoylacetonitrile
JP2517836B2 (en) Process for producing 4-chloroimidazole-5-carbaldehyde derivative
JP4483183B2 (en) Process for producing 6,7-dihydroxycoumarin-3-carboxylic acid derivative and its intermediate
JP4114911B2 (en) Method for producing 4-hydroxybenzenesulfonanilide
JPH03232846A (en) Production of n-ethyl-n-substituted aminophenols

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880120880.9

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08862198

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 206085

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 3539/CHENP/2010

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08862198

Country of ref document: EP

Kind code of ref document: A1